Peroxisome proliferator-activated receptor γ: a novel target for cancer therapeutics?
Authors:
- ShouWei HanSHShouWei Han
- Jesse RomanJRJesse Roman
- 1 March 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 18 (3) , 237-244
Abstract
Peroxisome proliferator-activated receptors are ligand-activated intracellular transcription factors that have been implicated in important biological processes such as inflammation, tissue remodeling and atherosclerosis. Emerging information also implicates peroxisome proliferator-activated receptors in oncogenesis. Peroxisome proliferator-activated receptor γ, the best studied of the peroxisome proliferator-activated receptors, modulates the proliferation and apoptosis of many cancer cell types, and it is expressed in many human tumors including lung, breast, colon, prostate and bladder. Natural and synthetic agents capable of activating peroxisome proliferator-activated receptor γ have been found to inhibit cancer cell growth in vitro and in animal models. These agents, however, are not specific and both peroxisome proliferator-activated receptor γ-dependent and peroxisome proliferator-activated receptor γ-independent pathways involved in their effects have been identified. Together, these studies, coupled with a few clinical trials, suggest that peroxisome proliferator-activated receptor γ is a novel target for the development of new and effective anticancer therapies.Keywords
This publication has 62 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptor γ and Growth Inhibition by Its Ligands in Uterine Endometrial CarcinomaClinical Cancer Research, 2006
- PPAR-γ ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cellsCancer Letters, 2006
- Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammationEuropean Journal of Pharmacology, 2006
- Inhibitors of the Arachidonic Acid Pathway and Peroxisome Proliferator–Activated Receptor Ligands Have Superadditive Effects on Lung Cancer Growth InhibitionCancer Research, 2005
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-?? IS A NEW THERAPEUTIC TARGET IN SEPSIS AND INFLAMMATIONShock, 2005
- PPARγ expression in breast cancer: clinical value and correlation with ERβHistopathology, 2005
- Up-regulation of p21 Gene Expression by Peroxisome Proliferator-Activated Receptor γ in Human Lung Carcinoma CellsClinical Cancer Research, 2004
- PPARγ signaling exacerbates mammary gland tumor developmentGenes & Development, 2004
- Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growthBiochemical and Biophysical Research Communications, 2004
- Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer CellsJournal of Biological Chemistry, 2002